Keith K Murai

Title: Keith K Murai: Innovator in Eph Receptor Modulation

Introduction

Keith K Murai is a notable inventor based in Candiac, Canada. He has made significant contributions to the field of biomedical research, particularly in the modulation of Eph receptor activity. His innovative work has the potential to impact therapeutic strategies in various medical applications.

Latest Patents

Keith K Murai holds a patent for "Agents that modulate Eph receptor activity." This patent describes novel agents that bind to Eph receptors, methods for using these agents to modulate receptor activity, stimulate apoptosis, and deliver therapeutic agents. Additionally, the patent outlines methods for screening agents capable of selectively binding to Eph receptors.

Career Highlights

Murai is associated with The Burnham Institute, where he has been involved in groundbreaking research. His work focuses on understanding the mechanisms of Eph receptors and their role in cellular processes. His contributions have been recognized within the scientific community, showcasing his expertise in the field.

Collaborations

Throughout his career, Keith K Murai has collaborated with esteemed colleagues, including Elena B Pasquale and Mitchell Koolpe. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.

Conclusion

Keith K Murai's innovative work in Eph receptor modulation exemplifies the impact of dedicated research in biomedical science. His contributions continue to pave the way for future advancements in therapeutic applications.